J&J to pay $28 million in Xarelto lawsuit

Discussion in 'Janssen' started by anonymous, Dec 6, 2017 at 6:48 AM.

  1. anonymous

    anonymous Guest

    Xarelto is the worst in class of the new blood thinners,” Michael Weinkowitz, the couple’s lawyer, said in a statement. “The serious health complications suffered by thousands of patients could have been avoided if physicians were properly instructed about the risks.”

    We’ve known all along the data was BS regarding bleeding. Whistleblowers unite.
     

  2. Asshole

    Asshole Guest

    Well your re org will certainly help that. Surprised they even let that cat out of the bag. Is that why Aetna dropped it? You guys have always know it is last in class and now it's official . Certain this is just the beginning of the bleeding.
     
  3. anonymous

    anonymous Guest

    Glad I am out of there and the pension check is nicely deposited the first day of the month.
     
  4. anonymous

    anonymous Guest

    Remember how they told us they prevailed in all the Carelto lawsuits bunch of B.S. they have lost battle against Eluquis and whenVA is given better pricing, it will be the ending he Federal Space too.
    So glad to get the hell out of this sinking ship. By the way, physicians have their minds made up. You can’t relaunch a product and that product is only as good as the Sales Force behind it. VP’s and President’s of Sales Divisions seem to forget, we are the one’s doing the heavy lifting and keeping lights on at Home Office.
    Start screwing with bonuses, laying off hard working sales teams to show your Q4 financial forecast and you will never recover, because sales force feels a sense of being unappreciated and demoralized. You deep what you soe.
    By the way, 1-800 Bad- Drug commercials are back too.
     
  5. anonymous

    anonymous Guest

    Maybe you should “soe”(sic) some grammar and spelling remedial courses......